Datavault AI Inc. 8-K

What Happened
Datavault AI Inc. announced a registered direct offering under a Securities Purchase Agreement dated May 3, 2026, to sell 109,090,910 shares of common stock at $0.55 per share for approximately $60.0 million in gross proceeds. The offering is expected to close on or about May 5, 2026, subject to customary closing conditions. The company said it intends to use net proceeds to deploy its “quantum‑ready graphics processing unit edge network” (build‑out and equipment) and for working capital and general corporate purposes. Titan Partners Group LLC (a division of American Capital Partners, LLC) is serving as placement agent.

Key Details

• Shares offered: 109,090,910 common shares at $0.55 per share (gross proceeds ≈ $60.0M).
• Expected closing: on or about May 5, 2026, subject to customary conditions.
• Placement agent compensation: $4.2 million cash fee plus warrants to purchase 5,454,545 shares (5‑year term, $0.6325 exercise price).
• FINRA treatment: Placement agent warrants and underlying shares are deemed compensation and subject to a 180‑day lock‑up under FINRA Rule 5110(e)(1) (with customary exceptions).
• Company restrictions: until 45 days after closing (subject to exceptions), the company and its subsidiaries generally may not issue or agree to issue common stock or common stock equivalents, file registration statements, or enter into Variable Rate Transactions per the Purchase Agreement.
• Offering registered on effective Form S‑3 (File No. 333‑294502); related press release and legal opinion (Paul Hastings LLP) filed as exhibits to the 8‑K.

Why It Matters
This financing provides Datavault AI with immediate capital to fund its planned GPU edge‑network deployment and general operations, which can help advance its product rollout without waiting for other funding sources. The share issuance will increase the number of outstanding shares and therefore dilute existing shareholders. Placement agent fees and warrants increase the total cost of the offering and add additional potential dilution when exercised (warrants exercisable at $0.6325 for five years). Investors should note the 45‑day issuance restrictions in the Purchase Agreement and the 180‑day FINRA lock‑up for the placement agent compensation, and that closing is subject to customary conditions and risks described in the filing.